tasimelteon 20 mg capsule
VP-VEC-162-4101
Approved small_molecule completed
Quick answer
tasimelteon 20 mg capsule for Non-24-Hour-Sleep-Wake Disorder is a Approved program (small_molecule) at Vanda Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals Netherlands B.V.
- Indication
- Non-24-Hour-Sleep-Wake Disorder
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed